Prosecution Insights
Last updated: October 02, 2026

UNIVERSITAET ULM

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

UNIVERSITAET ULM currently manages 2 pending office actions in the Medical Devices & Mechanical Engineering technology area. These applications are being reviewed by 2 distinct examiners across 2 distinct art units. This spread indicates that the university's filings are diverse enough to trigger reviews from different technical departments.

WOODALL, NICHOLAS W is the busiest examiner for the university, with 1 pending office action currently assigned. Given that there are 2 pending office actions in total, the workload is shared among 2 distinct examiners. This means each examiner is responsible for 1 case, providing a varied perspective on the technology during the prosecution process.

The involvement of 2 distinct art units suggests that the university's intellectual property spans multiple classifications within the Medical Devices & Mechanical Engineering field. With 2 pending office actions, the university maintains a steady but small volume of active prosecution. This data points to a portfolio that is beginning to diversify its technical footprint across 2 distinct examiners.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

5
Total Pending OAs
3
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (60%)
2
Medium (40%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other2 (40%)
§103 only2 (40%)
Multi-statute (no §101)1 (20%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

4
Life Sciences
80% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
20% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WOODALL, NICHOLAS W 1 82.0% +13.3%
NICKOL, GARY B 1 47.1% +31.1%
CHANDRA, GYAN 1 71.3% +27.5%
BOESEN, CHRISTIAN C 1 75.9% +21.1%
RODRIGUEZ, RAYNA B 1 33.6% +19.2%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18689178 RIGID, CURVED LARYNGOSCOPE WOODALL, NICHOLAS W 33d

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18274624 METHOD AND MEANS FOR MODULATING B-CELL MEDIATED IMMUNE RESPONSES NICKOL, GARY B —
18274605 METHOD AND MEANS FOR MODULATING B-CELL MEDIATED IMMUNE RESPONSES CHANDRA, GYAN —
17996457 METHOD FOR PROVIDING A MEDICAMENT COMBINATION AND DATA CARRIER WITH SOFTWARE BOESEN, CHRISTIAN C —

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
17255963 NEW MOLECULAR TWEEZERS AGAINST NEUROLOGICAL DISORDERS AND VIRAL INFECTIONS RODRIGUEZ, RAYNA B 29d overdue
18689178 RIGID, CURVED LARYNGOSCOPE WOODALL, NICHOLAS W 33d
18274624 METHOD AND MEANS FOR MODULATING B-CELL MEDIATED IMMUNE RESPONSES NICKOL, GARY B —
18274605 METHOD AND MEANS FOR MODULATING B-CELL MEDIATED IMMUNE RESPONSES CHANDRA, GYAN —
17996457 METHOD FOR PROVIDING A MEDICAMENT COMBINATION AND DATA CARRIER WITH SOFTWARE BOESEN, CHRISTIAN C —

Top Art Units

Art UnitApps
3775 1
1643 1
1674 1
1623 1
1628 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18689178 RIGID, CURVED LARYNGOSCOPE WOODALL, NICHOLAS W 3775 §103 Final Rejection 33d Pending Mar 05, 2024
18274624 METHOD AND MEANS FOR MODULATING B-CELL MEDIATED IMMUNE RESPONSES NICKOL, GARY B 1643 §101§102§112DP Non-Final OA — Pending Jul 27, 2023
18274605 METHOD AND MEANS FOR MODULATING B-CELL MEDIATED IMMUNE RESPONSES CHANDRA, GYAN 1674 §102§103§112 Non-Final OA — Pending Jul 27, 2023
17996457 METHOD FOR PROVIDING A MEDICAMENT COMBINATION AND DATA CARRIER WITH SOFTWARE BOESEN, CHRISTIAN C 1623 §101§103§112 Non-Final OA — Pending Oct 18, 2022
17255963 NEW MOLECULAR TWEEZERS AGAINST NEUROLOGICAL DISORDERS AND VIRAL INFECTIONS RODRIGUEZ, RAYNA B 1628 §103 Final Rejection 29d overdue Pending Dec 23, 2020

Managing UNIVERSITAET ULM's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month